Association between a four-parameter inflammatory index and all-cause mortality in critical ill patients with non-traumatic subarachnoid hemorrhage: a retrospective analysis of the MIMIC-IV database (2012-2019)

医学 重症监护室 倾向得分匹配 蛛网膜下腔出血 比例危险模型 内科学 回顾性队列研究 人口 危险系数 混淆 创伤性脑损伤 冲程(发动机) 生存分析 机械工程 置信区间 环境卫生 精神科 工程类
作者
Yongwei Huang,Ye Zhang,Zongping Li,Xiao-Shuang Yin
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:14 被引量:5
标识
DOI:10.3389/fimmu.2023.1235266
摘要

Non-traumatic subarachnoid hemorrhage (SAH), primarily due to the rupture of intracranial aneurysms, contributes significantly to the global stroke population. A novel biomarker, pan-immune-inflammation value (PIV) or called the aggregate index of systemic inflammation (AISI), linked to progression-free survival and overall survival in non-small-cell lung cancer and mortality in Coronavirus Disease 2019 (COVID-19) patients, has surfaced recently. Its role in non-traumatic SAH patients, however, remains under-researched. This study aims to determine the relationship between PIV and all-cause mortality in non-traumatic SAH patients.A retrospective analysis was conducted using data from the Medical Information Mart for Intensive Care (MIMIC-IV) database to examine the association between PIV and all-cause mortality in critically ill patients with non-traumatic SAH. PIV measurements were collected at Intensive Care Unit (ICU) admission, and several mortality measures were examined. To control for potential confounding effects, a 1:1 propensity score matching (PSM) method was applied. The optimal PIV cutoff value was identified as 1362.45 using X-tile software that is often used to calculate the optimal cut-off values in survival analysis and continuous data of medical or epidemiological research. The relationship between PIV and short- and long-term all-cause mortality was analyzed using a multivariate Cox proportional hazard regression model and Kaplan-Meier (K-M) survival curve analysis. Interaction and subgroup analyses were also carried out.The study included 774 non-traumatic SAH patients. After PSM, 241 pairs of score-matched patients were generated. The Cox proportional hazard model, adjusted for potential confounders, found a high PIV (≥ 1362.45) independently associated with 90-day all-cause mortality both pre- (hazard ratio [HR]: 1.67; 95% confidence intervals (CI): 1.05-2.65; P = 0.030) and post-PSM (HR: 1.58; 95% CI: 1.14-2.67; P = 0.042). K-M survival curves revealed lower 90-day survival rates in patients with PIV ≥ 1362.45 before (31.1% vs. 16.1%%, P < 0.001) and after PSM (68.9% vs. 80.9%, P < 0.001). Similarly, elevated PIV were associated with increased risk of ICU (pre-PSM: HR: 2.10; 95% CI: 1.12-3.95; P = 0.02; post-PSM: HR: 2.33; 95% CI: 1.11-4.91; P = 0.016), in-hospital (pre-PSM: HR: 1.91; 95% CI: 1.12-3.26; P = 0.018; post-PSM: 2.06; 95% CI: 1.10-3.84; P = 0.034), 30-day (pre-PSM: HR: 1.69; 95% CI: 1.01-2.82; P = 0.045; post-PSM: 1.66; 95% CI: 1.11-2.97; P = 0.047), and 1-year (pre-PSM: HR: 1.58; 95% CI: 1.04-2.40; P = 0.032; post-PSM: 1.56; 95% CI: 1.10-2.53; P = 0.044) all-cause mortality. The K-M survival curves confirmed lower survival rates in patients with higher PIV both pre- and post PSM for ICU (pre-PSM: 18.3% vs. 8.4%, P < 0.001; post-PSM:81.7 vs. 91.3%, P < 0.001), in-hospital (pre-PSM: 25.3% vs. 12.8%, P < 0.001; post-PSM: 75.1 vs. 88.0%, P < 0.001), 30-day (pre-PSM: 24.9% vs. 11.4%, P < 0.001; post-PSM:74.7 vs. 86.3%, P < 0.001), and 1-year (pre-PSM: 36.9% vs. 20.8%, P < 0.001; P = 0.02; post-PSM: 63.1 vs. 75.1%, P < 0.001) all-cause mortality. Stratified analyses indicated that the relationship between PIV and all-cause mortality varied across different subgroups.In critically ill patients suffering from non-traumatic SAH, an elevated PIV upon admission correlated with a rise in all-cause mortality at various stages, including ICU, in-hospital, the 30-day, 90-day, and 1-year mortality, solidifying its position as an independent mortality risk determinant. This study represents an attempt to bridge the current knowledge gap and to provide a more nuanced understanding of the role of inflammation-based biomarkers in non-traumatic SAH. Nevertheless, to endorse the predictive value of PIV for prognosticating outcomes in non-traumatic SAH patients, additional prospective case-control studies are deemed necessary.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lzzy发布了新的文献求助10
1秒前
1秒前
2秒前
2秒前
书剑飞侠完成签到,获得积分10
3秒前
领导范儿应助HHZ采纳,获得10
3秒前
星辰大海应助贪玩的秋柔采纳,获得10
3秒前
6秒前
上官若男应助王泰一采纳,获得10
6秒前
科研通AI2S应助王泰一采纳,获得10
6秒前
Jasper应助王泰一采纳,获得10
6秒前
Singularity应助王泰一采纳,获得10
6秒前
酷波er应助王泰一采纳,获得10
6秒前
Singularity应助王泰一采纳,获得10
6秒前
我是老大应助王泰一采纳,获得10
6秒前
田様应助王泰一采纳,获得10
6秒前
我就是个傻福应助王泰一采纳,获得150
6秒前
田様应助王泰一采纳,获得80
6秒前
zzz完成签到,获得积分10
6秒前
牟翎发布了新的文献求助10
8秒前
渭阳野士完成签到,获得积分10
10秒前
11秒前
鼻揩了转去应助王泰一采纳,获得10
12秒前
慕青应助王泰一采纳,获得10
12秒前
Singularity应助王泰一采纳,获得10
12秒前
大模型应助王泰一采纳,获得10
13秒前
13秒前
怡然的凌兰应助王泰一采纳,获得10
13秒前
慕青应助王泰一采纳,获得10
13秒前
情怀应助王泰一采纳,获得10
13秒前
科研狗应助王泰一采纳,获得150
13秒前
科研狗应助王泰一采纳,获得80
13秒前
www应助王泰一采纳,获得10
13秒前
Shawn发布了新的文献求助10
13秒前
Rainyin发布了新的文献求助10
15秒前
俭朴熊猫发布了新的文献求助10
16秒前
香蕉觅云应助HHZ采纳,获得10
16秒前
17秒前
大个应助勇勇帝国采纳,获得10
18秒前
11111发布了新的文献求助10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Emmy Noether's Wonderful Theorem 1200
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
基于非线性光纤环形镜的全保偏锁模激光器研究-上海科技大学 800
Signals, Systems, and Signal Processing 610
Wade & Forsyth's Administrative Law 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6410276
求助须知:如何正确求助?哪些是违规求助? 8229593
关于积分的说明 17461859
捐赠科研通 5463374
什么是DOI,文献DOI怎么找? 2886728
邀请新用户注册赠送积分活动 1863166
关于科研通互助平台的介绍 1702351